glp-1 drug companies 3 Stock Picks: LLY, VKTX, and GPCR GLP-1 Drug Savings: A Complete
Description
doi: 10.1016/j.parkreldis.2015.10.006 [DOI] [PubMed] [Google Scholar] 135.Klausen MK, Jensen ME, Mller M, et al
Social, clinical, and policy implications of ultra-processed food addiction
The discovery of glucagon-like peptide 1 (GLP- 1) analogs pointed to the significant promise of gut hormones in the management of T2DM and obesity
124 GLP-1, by activating its receptor, increases insulin secretion and reduces glucagon secretion, thereby lowering blood sugar levels
Additional dual agents that target GLP-1 and GIP include Tirzepatide, which has shown to provide greater glycemic control compared to available single agonist agents
